Previous 10 | Next 10 |
2023-11-07 23:08:07 ET Inogen, Inc. (INGN) Q3 2023 Results Conference Call November 07, 2023 05:00 PM ET Company Participants Marissa Bych - IR Gilmartin Group Nabil Shabshab - President and CEO Mike Sergesketter - Interim CFO Conference Call Participants ...
2023-11-07 16:14:59 ET More on Inogen Inogen: Gasping After Strategic Choices Drive Steep Sales And Margin Declines (Rating Downgrade) Inogen Q3 2023 Earnings Preview Inogen names Mike Sergesketter interim CFO, reaffirms 2023 annual revenue expectations Seeki...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended September 30, 2023. Third Quarter 2023 and Recent Business Highlights Reported total rev...
Weyco Group Inc. (WEYS) is expected to report for Q1 2024 Gladstone Land Corporation (LAND) is expected to report $0.16 for Q3 2023 PlayAGS Inc. (AGS) is expected to report $0.01 for Q3 2023 Ardmore Shipping Corporation (ASC) is expected to report $0.43 for Q3 2023 Sage Therapeuti...
Inogen Inc (INGN) is expected to report $-0.56 for Q3 2023
2023-10-13 23:58:49 ET Summary Inogen has struggled to recover from post-pandemic disruptions and successfully implement a mixed purchase and rental business model. The DTC business has been hit hard by salesforce departures, and management is once again looking to rebuild the sal...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report third quarter 2023 financial results after the market closes on Tuesday, November 7, 2023. On the same day, the Company wi...
Acquisition Expands Inogen’s Global Respiratory Care Presence by Addressing the Sizeable, Growing and Underserved Airway Clearance Market Opportunity Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecar...
2023-09-07 09:57:10 ET More on Inogen Seeking Alpha’s Quant Rating on Inogen Historical earnings data for Inogen Financial information for Inogen Inogen, Inc. ( INGN ) Q2 2023 Earnings Call Transcript Inogen: Still Struggling, But Very Chea...
2023-08-08 10:21:19 ET Gainers: Bright Minds Biosciences ( DRUG ) +62% . Bionomics ( BNOX ) +24% . Novo Nordisk ( NVO ) +18% . Quanterix ( QTRX ) +17% . Tilray Brands ( TLRY ) +18% . Losers: Vistagen Therapeutics ( VTGN ...
News, Short Squeeze, Breakout and More Instantly...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report second quarter 2024 financial results after the market closes on Tuesday, August 6, 2024. On the same day, the Company wil...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Kevin P. Smith as General Counsel and Executive Vice President, Business Development, effective July 22, 2024. Mr. Smith jo...